ANI has launched ketoconazole shampoo, 2%, which is the generic of Nizoral.
"We are proud to announce the FDA approval and commercialization of ketoconazole shampoo, 2%, another limited competition product. ANI’s talented R&D team continues to execute on our key strategic priority to consistently and effectively launch new products that address the needs of patients,” said Nikhil Lalwani, president and CEO of ANI.
[Read more: ANI Pharmaceuticals receives FDA nod for generic Furadantin]
Ketoconazole shampoo, 2%, had a market value of approximately $69.2 million, per July 2024 IQVIA data.
[Read more: ANI intros generic Trental]